Lia Terapi AS
Not financial advice. The index, rank, signals and advice are rule-based indications from the latest filed annual accounts. They are not a credit rating, an assessment of management or a recommendation to buy, sell or do business with the company. Read more
Key facts
Is the company run well?
Five key figures against companies in the Morning class Micro in the same sector. Green is better than most, amber about like the industry and red weaker than most.
- Profitability · operating margin 7.9% About like the industry Industry: 5.1%
- Returns · return on assets 7.7% About like the industry Industry: 9.7%
- Solidity · equity ratio 14.3% Weaker than the industry Industry: 37.0%
- Liquidity · current ratio 1.98 Better than the industry Industry: 1.51
- Growth · revenue growth 6.0% About like the industry Industry: 5.7%
The mark comes from the company's place among comparable companies (percentile): green from 60, amber from 40, red below 40. Negative equity, an operating loss and a current ratio under 1 pull it down regardless. Methodology
Score · fiscal year 2025
46of 100
How to read this: the company is ahead of 43 % of companies in the Morning class Micro in the same sector in 2025. What does this mean?
Rank in the Morning class Micro: 1,341 of 2,340 · What are Morning company classes?
Place in the whole sector: 1,774 of 3,039 · Kultur og fritid
Profile
Cheetah · Sprinter
High profitability, lower resilience
Position against comparable companies in 2025, not a verdict on the company. Based on profitability 52 and resilience 34 out of 100 among companies in the Morning class Micro in the same sector in 2025. Methodology
Against the sector
Lia Terapi AS is 5 points below the median for companies in the Morning class Micro in the same sector in 2025.
Median score 51 among 2,337 companies.
Against companies in the Morning class Micro in the same sector in 2025: operating margin 7.9% (median 5.1%) and equity ratio 14.3% (median 37.0%).
How it has gone · 2023–2025
Revenue rose by 19 % from 2023 to 2025, to 5.8 MNOK. The operating margin rose from −8.3% in 2023 to 7.9% in 2025. The equity ratio rose from 12.7% in 2023 to 14.3% in 2025.
Amounts in the reporting currency. The full year-by-year table is further down under «Details». See every figure year by year
Accounts in short
| Key figure | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating revenue | 4.8 MNOK | 5.4 MNOK | 5.8 MNOK |
| Operating profit | −0.4 MNOK | 0.3 MNOK | 0.5 MNOK |
| Net profit | −0.6 MNOK | 0.0 MNOK | 0.1 MNOK |
| Total assets | 5.8 MNOK | 5.9 MNOK | 6.0 MNOK |
| Equity | 0.7 MNOK | 0.7 MNOK | 0.9 MNOK |
| Total liabilities | 5.1 MNOK | 5.2 MNOK | 5.1 MNOK |
From the Brønnøysund Register Centre, in the company's reporting currency (NOK). See every figure year by year
From the Central Coordinating Register
- Org. no.
- 984494467
- Legal form
- AS
- Sector
- Kultur og fritid (93.130)
- Purpose
- Drift av treningssenter, herav manuell terapi, idrettsfysioterapi og medesinsk treningsterapi.
- Morning company class
- Micro
- Employees
- 0–4 (not registered) Payroll costs in the accounts: 2.5 MNOK (2025).
- Founded
- 24 April 2002 24 years in operation
- Share capital
- 0.10 MNOK
- Business address
- Liavegen 11, 2420 TRYSIL
- Municipality
- Trysil rank 26–39 of 39 in KOSTRA group 4
- Audit
- Audit opted out from 22 December 2011
- Latest accounts filed
- 2025
- VAT registered
- No
Source: Central Coordinating Register, Brønnøysund Register Centre. The employee count is reported by the company and may be older than the accounts. See the company at the Brønnøysund Register Centre
Lia Terapi AS has a score of 46 for 2025, rank 1,774 of 3,039 in the sector.
Strongest: Liquidity: percentile 61 against peers, current ratio 1.98 against a median of 1.51.
Weakest: Solidity: percentile 24 against peers, equity ratio 14.3% against a median of 37.0%.
Worth a closer look
- Receivables equal far more days of revenue than at comparable companies. Do customers pay late, or are these loans to companies in the same group? Based on: receivable days 58 days (median 22 days).
- What lies behind weak solidity, and will it last?
- The change in operating margin in 2025 was 2.4 percentage points better than for comparable companies: the company +2.5, the industry +0.1 points. That is the company's own, not something that hit the whole industry.
Written by fixed rules from the figures. Describes the figures, does not explain causes. Not investment or financial advice. How the summary is made
Worth a closer look
- watch
Receivables equal far more days of revenue than at comparable companies. Do customers pay late, or are these loans to companies in the same group?
Based on: Receivable days 58 days (median 22 days).
Indications based on the latest annual accounts from open data. Not investment or financial advice.
Financial costs were 5.8% of the debt in 2025. The policy rate averaged 4.30 % the same year. This is a plain description of what the debt cost, not a model of interest sensitivity.
See interest rates, prices and exchange rates for the sector
Data quality
No anomalies found in the figures.
Scenario analysis: the sector's weakest year
We have no accounts for 2026, the sector's weakest year, for this company.
The sector's weakest year was 2026, with a median operating margin of 1.4%. Based on the 8 fiscal years we have. The analysis grows as more years are fetched or imported. Methodology
What the score is made of
| Profitability | 52 | weight 40% |
|---|---|---|
| Solidity | 24 | weight 20% |
| Liquidity | 61 | weight 5% |
| Growth | 54 | weight 25% |
| Consistency | 41 | weight 10% |
Three goals: profitability 40%, growth 25%, resilience 35%. Why these weights?
Durability: 40 (average over 3 years)
Index version 3. Data completeness 100%: the share of the weights that had data.
The numbers behind the score
| Measure | Company | Median |
|---|---|---|
| Operating revenue | 6 MNOK | 3 MNOK |
| Operating margin | 7.9% | 5.1% |
| Profit margin | 2.8% | 4.3% |
| Return on assets | 7.7% | 9.7% |
| Equity ratio | 14.3% | 37.0% |
| Debt-to-equity | 5.99 | 1.09 |
| Current ratio | 1.98 | 1.51 |
| Revenue growth | 6.0% | 5.7% |
The median and “ahead of” refer to companies in the Morning class Micro in the same sector in 2025. The bar shows the share of companies the figure is ahead of.
With an index of 46, Lia Terapi AS does better than 43% of companies in the Morning class Micro in the same sector (2,340 companies) in 2025.
Score 2023–2025
- Lia Terapi AS
- Median: companies in the Morning class Micro in the same sector
Working capital and debt
| Measure | Company | Median | |
|---|---|---|---|
| Working capital | |||
| Receivable days All current receivables, including those on group companies, in days of revenue. |
58 days | 22 days | |
| Inventory and other current assets, days Current assets other than receivables and bank deposits, that is inventory and short-term investments, in days of revenue. |
0 days | 0 days | |
| Net working capital to revenue Current assets less bank deposits less current liabilities, divided by revenue. Negative: short-term debt funds the operations. |
2.6% | −7.7% | |
| Cash share of current assets How much of the short-term buffer is bank deposits and cash. |
39.7% | 64.2% | |
| Debt and interest burden | |||
| Interest coverage (times) Operating result divided by all financial costs. Below 1: operations do not cover the cost of the debt. |
1.5 | 5.5 | |
| Financial costs as a share of debt All financial costs (interest, currency losses and other) divided by all debt, interest-free debt included. Not an interest rate. |
5.8% | 0.9% | |
| Long-term share of debt Long-term debt as a share of all debt. A low share means more falls due within a year. |
85.1% | 24.8% | |
Net working capital (current assets less bank deposits less current liabilities): 0.1 MNOK.
Of the financial costs of 0.3 MNOK, 0.3 MNOK is reported as interest costs in the accounts.
The median and the bar refer to companies in the Morning class Micro in the same sector in 2025. The bar shows the share of the group with a lower figure: higher is not always better, long receivable days tie up capital, for example. These figures do not count in the score.
The industry or the company: what drove the result?
In 2025 the operating margin of Lia Terapi AS rose by 2.5 percentage points. Comparable companies rose by a median 0.1 points. So the company did 2.4 points better than the industry, for reasons of its own.
Over 2 year-to-year changes Lia Terapi AS moved the same way as comparable companies 1 times. About 3% of the changes in operating margin were common to the industry; the rest was the company's own.
| Year | The company | Comparable (median) | Change, company | Change, industry | The company's own |
|---|---|---|---|---|---|
| 2024 | 5.5% | 5.0% | +13.7 percentage points | +0.4 percentage points | +13.4 percentage points |
| 2025 | 7.9% | 5.1% | +2.5 percentage points | +0.1 percentage points | +2.4 percentage points |
Comparable companies are those in the same industry and Morning company class. Their change shows what hit the whole industry, the sector drivers below included. The rest is the company's own: contracts, costs, one-off items or operations. The share is approximate, and we claim no cause.
The company and its sector's drivers
Prices, rate and currency that shape the sector's year, year by year beside the operating margin of Lia Terapi AS. The figures stand side by side; we claim no cause.
Consumer price index (indeks (2025 = 100))
Consumer price index rose 3.0% in 2025; the operating margin of Lia Terapi AS rose 2.5 percentage points.
| Measure | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Consumer price index, annual average | 84.3 | 89.2 | 94.1 | 97.0 | 100.0 | 103.0 (so far) |
| Change from the year before | +3.5% | +5.8% | +5.5% | +3.2% | +3.0% | +3.0% |
| The company's operating margin | – | – | −8.3% | 5.5% | 7.9% | – |
Source: SSB (14710, CC BY 4.0). Source
Policy rate (prosent)
Policy rate fell 0.20 percentage points in 2025; the operating margin of Lia Terapi AS rose 2.5 percentage points.
| Measure | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Policy rate, annual average | 0.08 | 1.32 | 3.54 | 4.50 | 4.30 | 4.17 (so far) |
| Change from the year before | −0.28 percentage points | +1.24 percentage points | +2.22 percentage points | +0.96 percentage points | −0.20 percentage points | −0.12 percentage points |
| The company's operating margin | – | – | −8.3% | 5.5% | 7.9% | – |
Source: Norges Bank (IR, NLOD 2.0). Source
Wage index: sports and recreation (indeks)
Wage index: sports and recreation rose 6.7% in 2025; the operating margin of Lia Terapi AS rose 2.5 percentage points.
| Measure | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Wage index: sports and recreation, annual average | 84.2 | 89.2 | 94.0 | 98.8 | 105.5 | 112.7 (so far) |
| Change from the year before | +2.0% | +6.0% | +5.4% | +5.2% | +6.7% | +6.8% |
| The company's operating margin | – | – | −8.3% | 5.5% | 7.9% | – |
Source: SSB (12314, CC BY 4.0). Source
We show the drivers and the margin side by side and claim no cause. Sensitivity per company is not computed until we have at least 10 years of accounts per company: with three years such figures are false precision.
What the numbers say
Lia Terapi AS had an operating margin of 7.9% and an equity ratio of 14.3% in 2025, and ranks 1,774 of 3,039 in Kultur og fritid.
From 2024 to 2025: went from a loss to a profit before tax and the operating margin rose from 5.5% to 7.9%.
This text is generated automatically from the 2025 accounts.
Three simple methods
One method gives a figure: 2 MNOK.
| Method | Multiple | Estimate |
|---|---|---|
| P/E | 21.1 | not meaningful |
| EV/EBIT | 19.9 | debt above value |
| P/B | 3.3 | 2 MNOK |
| EV/EBIT: from enterprise value to equity | NOK |
|---|---|
| Enterprise value (EV) at the listed multiple | 2 MNOK |
| Enterprise value after the size adjustment | 1 MNOK |
| Less net debt (rough figure) | 4 MNOK |
| Equity value | debt above value |
Net debt is a rough figure: long-term liabilities minus cash. The accounts do not split interest-bearing debt from other liabilities, and short-term borrowings are not included. The size adjustment applies to the enterprise value, not to the debt. Net debt is 262% of the enterprise value after the size adjustment, so the equity value from EV/EBIT is sensitive to errors in the debt figure.
The listed basis is the value at listed multiples. The estimate is lowered for size: a small-company premium of 4% on the cost of equity gives a value 38% lower. No separate marketability discount is applied, because the premium already allows for the company being small and unlisted.
The NACE code has no listed industry of its own in the table, so the multiples are the sector median: Recreation.
Not financial advice. The value range is a rough model estimate from listed-company multiples, not a valuation, a price target or a price offer. The actual value may differ greatly. Read more
A mechanical estimate from public accounts, not advice. A mechanical estimate from public accounts with listed multiples and fixed adjustments. Not a valuation and not advice to buy or sell. See the calculation
Questions and answers
How profitable is Lia Terapi AS?
The operating margin was 7.9% in 2025, against a median of 5.1% among companies in the Morning class Micro in the same sector. Return on assets was 7.7%.
How solid is Lia Terapi AS?
The equity ratio was 14.3% in 2025 (median 37.0%). Debt-to-equity was 5.99 (median 1.09).
What is the liquidity of Lia Terapi AS like?
The current ratio was 1.98 in 2025 (median 1.51).
How does Lia Terapi AS compare in Kultur og fritid?
Lia Terapi AS ranks 1,774 of 3,039 in Kultur og fritid for 2025. Among companies in the Morning class Micro it is number 1,341 of 2,340. Revenue changed by 6.0% from the year before.
Competitors
The 8 closest competitors in the same line of business, placed in the same matrix as the sector page: profitability up, resilience to the right. These are the companies the competitor analysis and the strategy report compare with.
Each bubble is a company: this company and its closest competitors in the same line of business and size, the same ones the competitor analysis uses. Placement is 0–100 against the whole sector and Morning company class: further right is more robust, higher up is more profitable. Bubble size is revenue. The light bubble and arrow show where the company stood the year before. Pick a profile to see fewer at a time.
| Company | Profile | Operating revenue | Operating margin | Score |
|---|---|---|---|---|
| Bislet Bad og Trening AS | 9 MNOK | −1.1% | 31 | |
| Skoi Trening og Helse AS | 8 MNOK | 5.4% | 44 | |
| Basic Norge AS | 7 MNOK | −5.3% | 17 | |
| Lia Terapi AS (this company) | 6 MNOK | 7.9% | 46 | |
| Apexklinikken Drift AS | 5 MNOK | 6.8% | 55 | |
| Saga FT AS | 5 MNOK | 10.3% | 60 | |
| GJERDRUM FYSIOTERAPI & Trening AS | 4 MNOK | 4.1% | 57 | |
| SENTRUM FYSIOTERAPI & Trening AS | 4 MNOK | 5.0% | 63 | |
| Trimfit AS | 3 MNOK | 29.9% | 73 |
The selection is the closest in revenue within the same industry code. When you order, you can swap competitors. Order competitor analysis
Ownership and roles
Loading roles …
Source: Central Coordinating Register, fetched 7 November 2026. Only names are shown.
Shareholders (2025)
- Number of shareholders
- 2
- Largest owner
- 50.0%
- Split
- companies 0% · private persons 100% · foreign 0%
- Owned from the same municipality
- 100%
Change 2007–2025: no material change in the owners.
The portfolio: 3 of the companies it owns shares in have accounts with us, 0 of them as majority owner. The average index is 49. 1 have negative equity and 2 made a loss in the latest year.
Holds shares in: Trysil Bryggeri AS (1%), Snygarden AS (50%), Spenst Norge AS (3%)
Source: the Norwegian Tax Administration's shareholder register as of 2025. Figures may be older than today's ownership. Private persons are not shown by name.
Error in the data?
Do you see an error in the figures or in how the company is mapped (sector, holding, group)? Let us know. Corrections require documentation.
Is this your company? Suggest changes or add information
Figures last fetched 9 November 2026.
Year by year · 2023–2025
| Key figure | 2023 | 2024 | 2025 | Trend |
|---|---|---|---|---|
| Index | 26 | 47 | 46 | |
| Rank | 2,228 | 1,658 | 1,774 | |
| Operating margin | −8.3% | 5.5% | 7.9% | |
| Return on assets | −6.8% | 5.1% | 7.7% | |
| Equity ratio | 12.7% | 12.3% | 14.3% | |
| Current ratio | 1.63 | 1.86 | 1.98 | |
| Revenue growth | – | 12.0% | 6.0% |
Accounts
From the Brønnøysund Register Centre, in the company's reporting currency (NOK).
| Key figure | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating revenue | 4.8 MNOK | 5.4 MNOK | 5.8 MNOK |
| Operating profit | −0.4 MNOK | 0.3 MNOK | 0.5 MNOK |
| Profit before tax | −0.7 MNOK | 0.0 MNOK | 0.2 MNOK |
| Tax expense | −0.1 MNOK | 0.0 MNOK | 0.0 MNOK |
| Net profit | −0.6 MNOK | 0.0 MNOK | 0.1 MNOK |
| Financial expenses | 0.3 MNOK | 0.3 MNOK | 0.3 MNOK |
| Total assets | 5.8 MNOK | 5.9 MNOK | 6.0 MNOK |
| Current assets | 1.0 MNOK | 1.2 MNOK | 1.5 MNOK |
| Equity | 0.7 MNOK | 0.7 MNOK | 0.9 MNOK |
| Retained earnings | 0.6 MNOK | 0.6 MNOK | 0.8 MNOK |
| Total liabilities | 5.1 MNOK | 5.2 MNOK | 5.1 MNOK |
| Current liabilities | 0.6 MNOK | 0.6 MNOK | 0.8 MNOK |
Source: Brønnøysund Register Centre (Register of Company Accounts), fetched 9 November 2026, accounts id 6623889.
Further
Similar companies
- Que Professional AS index 46, rank 1,772 · compare
- Flightcase BY Skarding AS index 46, rank 1,773 · compare
- Sandvika Bingo AS index 46, rank 1,775 · compare
- Elavit AS index 46, rank 1,776 · compare
- Cirkus Balance AS index 46, rank 1,777 · compare
News and announcements
- 6 November 2026 Endring i styret (opens in a new tab) Source: Brønnøysundregistrene
From official sources: the Brønnøysund Register Centre, Oslo Børs NewsWeb and public agencies. We show the title, date and a link to the source. The link to a company, sector or municipality is automatic and may be wrong. Report a wrong link